Comorbidity and survival after admission to the intensive care unit: A population-based study of 41,230 patients.
Comorbidities
haematological malignancy
liver disease
mortality
solid malignancy
Journal
Journal of the Intensive Care Society
ISSN: 1751-1437
Titre abrégé: J Intensive Care Soc
Pays: England
ID NLM: 101538668
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
entrez:
24
5
2021
pubmed:
25
5
2021
medline:
25
5
2021
Statut:
ppublish
Résumé
To describe the relationship between comorbidities and survival following admission to the intensive care unit. Retrospective observational study using several linked routinely collected databases from 16 general intensive care units between 2002 and 2011. Comorbidities identified from hospitalisation in the five years prior to intensive care unit admission. Odds ratios for survival in intensive care unit, hospital and at 30 days, 180 days and 12 months after intensive care unit admission derived from multiple logistic regression models. There were 41,230 admissions to intensive care units between 2002 and 2011. Forty-one percent had at least one comorbidity - 24% had one, 17% had more than one. Patients with comorbidities were significantly older, had higher Acute Physiology and Chronic Health Evaluation II scores and were more likely to have received elective rather than emergency surgery compared with those without comorbidities. After excluding elective hospitalisations, intensive care unit and hospital mortality for the cohort were 24% and 29%, respectively. Asthma (odds ratio 0.79, 95% confidence interval 0.63-0.99) and solid tumours (odds ratio 0.74, 0.67-0.83) were associated with lower odds of intensive care unit mortality than no comorbidity. Intensive care unit mortality was raised for liver disease (odds ratio 2.98, 2.43-3.65), cirrhosis (odds ratio 2.61, 1.9-3.61), haematological malignancy (odds ratio 2.29, 1.85-2.83), chronic ischaemic heart disease (odds ratio 1.53, 1.19-1.98), heart failure (odds ratio 1.79, 1.35-2.39) and rheumatological disease (odds ratio 1.53, 1.18-1.98). Comorbidities affect two-fifths of intensive care unit admission and have highly variable effects on subsequent outcomes. Information on the differential effects of comorbidities will be helpful in making better decisions about intensive care unit support and understanding outcomes beyond surviving intensive care unit.
Identifiants
pubmed: 34025754
doi: 10.1177/1751143720914229
pii: 10.1177_1751143720914229
pmc: PMC8120566
doi:
Types de publication
Journal Article
Langues
eng
Pagination
143-151Informations de copyright
© The Intensive Care Society 2020.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
JAMA Oncol. 2015 Nov;1(8):1078-85
pubmed: 26313462
BMJ. 2007 Dec 1;335(7630):1132
pubmed: 17975254
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
Crit Care. 2009;13(1):R15
pubmed: 19200368
Crit Care. 2007;11(2):R50
pubmed: 17451605
Eur J Heart Fail. 2006 Nov;8(7):697-705
pubmed: 16516552
Acta Oncol. 2012 Sep;51(7):897-905
pubmed: 22548367
J Clin Epidemiol. 2004 Dec;57(12):1288-94
pubmed: 15617955
Lancet. 2012 Jul 7;380(9836):37-43
pubmed: 22579043
Crit Care Med. 1999 Mar;27(3):633-8
pubmed: 10199547
Aliment Pharmacol Ther. 2010 Jul;32(2):233-43
pubmed: 20456304
Crit Care Med. 2011 Dec;39(12):2728-35
pubmed: 22094497
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Ann Intensive Care. 2011 Mar 23;1(1):5
pubmed: 21906331
Intensive Care Med. 2014 Oct;40(10):1409-28
pubmed: 25223853
Eur J Heart Fail. 2001 Jun;3(3):315-22
pubmed: 11378002
J Health Serv Res Policy. 2008 Apr;13 Suppl 2:40-4
pubmed: 18416928